Health
Dizal's Golidocitinib Pivotal Trial Demonstrates Superior and Durable Clinical Benefits for Patients with r/r PTCL in Oral Presentation at 2023 ASH
* Full analysis of multinational pivotal study results of golidocitinib in relapsed or refractory peripheral T-cell lymphoma (r/r PTCL) (JACKPOT8 PART B) simultaneously published inThe Lancet Oncology and presented in oral session at the 65th American Society of Hematology Annual Meeting and Ex...
2023-12-10 18:00
1333
Menarini Group Presents New Progression-Free Survival Data from EMERALD Clinical Study of ORSERDU® (Elacestrant) in Clinically Relevant Subgroups of Patients with ER+, HER2- Metastatic Breast Cancer (mBC) with ESR1 Mutations at SABCS 2023
* This new post hoc analysis of the Phase 3 EMERALD trial evaluated elacestrant in the endocrine-sensitive population (CDK4/6 inhibitor duration of at least 12 months) with tumors harboring ESR1 mutations. * This analysis shows a clinically meaningful improvement in progression-free survivala...
2023-12-08 23:13
3292
RewirEd Summit at COP28 makes history by bringing education to the forefront of climate action to impact billions of children and youth globally
DUBAI, UAE, Dec. 8, 2023 /PRNewswire/ -- RewirEd Summit, the first ever global education summit on climate brought together 1,000 participants, including 2 heads of state, 22 ministers, and 28 CEOs, with 260 speakers from diverse sectors, representing 209 entities and 76 countries, to address urg...
2023-12-08 22:06
2167
C.P. Group and Toyota/Commercial Japan Partnership Technologies achieved new milestones towards decarbonization with multi-faceted solutions across energy, data and mobility
* A joint partnership by Charoen Pokphand Group (C.P. Group), Toyota Motor Corporation (TMC) and Commercial Japan Partnership Technologies (CJPT) announced the successful pilot project for biogas-derived hydrogen production in Thailand. * C.P. Group plans to use such biogas-derived hydrogen fo...
2023-12-08 17:57
2446
WuXi Biologics Awarded Highest Platinum Medal by EcoVadis Sustainability Rating
* Ranked in top 1% of the over 100,000 companies evaluated * Recognized for outstanding performance across all areas: Environment, Labor & Human Rights, Ethics, and Sustainable Procurement * Seen as a trusted partner by global clients for its strong sustainability commitment SHANGHAI, Dec. 8...
2023-12-08 17:40
3527
Whole Exome Sequencing Advancements in Unraveling Rare Diseases in Japan
TOKYO, Dec. 8, 2023 /PRNewswire/ -- According to Estimation of the Number of
Patients With Mitochondrial Diseases: A Descriptive Study Using in a nationwide
database inJapan
2023-12-08 13:40
1637
PharmaBlock Officially Joins United Nations Global Compact
NANJING, China, Dec. 8, 2023 /PRNewswire/ -- PharmaBlock Sciences (Nanjing), Inc. (Stock code: 300725.SZSE), a global, fully integrated CRDMO company, focusing on innovative chemistry and low-carbon manufacturing, has officially joined the United Nations Global Compact (UNGC), which not only affi...
2023-12-08 12:37
1247
CStone Announces NMPA Approval of Sugemalimab as First-line Treatment for Esophageal Squamous Cell Carcinoma
* Sugemalimab is the world's first anti-PD-L1 monoclonal antibody approved for use in combination with fluorouracil and platinum-based chemotherapy for unresectable locally advanced, recurrent or metastatic esophageal squamous cell carcinoma. * This marks the 13th NDA approval obtained by CSt...
2023-12-08 12:10
4896
CU Medicine study published in The Lancet Infectious Diseases concludes that a novel oral microencapsulated live bacteria consortia (SIM01) alleviates long COVID symptoms
HONG KONG, Dec. 8, 2023 /PRNewswire/ -- A randomised, double-blind, placebo-controlled trial (RECOVERY STUDY) conducted by TheChinese University of Hong Kong (CUHK)'s Faculty of Medicine (CU Medicine) and Microbiota I-Center (MagIC) showed that an oral microbiome microencapsulated formula (SIM01)...
2023-12-08 10:38
1766
Full-Life Technologies Breaks Ground for GMP Manufacturing Facility in Belgium to Advance Its End-to-end Solution for Radiopharmaceuticals
GEMBLOUX, Belgium, Dec. 7, 2023 /PRNewswire/ -- Full-Life Technologies (Full-Life), a fully integrated global radiotherapeutics company, today announced the construction of its new Good Manufacturing Practices (GMP) compliant manufacturing facility in Gembloux,Belgium, for radiopharmaceuticals. ...
2023-12-08 10:00
1227
Infinitus Co-organizes 2023 Responsibilities for Health Forum: Fostering Quality and Innovation in Traditional Chinese Medicine
GUANGZHOU, China, Dec. 8, 2023 /PRNewswire/ – The 2023 Responsibilities for Health Forum (RHF) was held onDecember 4th, serving as a major event within the 2023 Boao Forum for Chinese Entrepreneurs. The larger forum took place in Boao, Hainan province from December 2nd to December 5th. Hosted by ...
2023-12-08 09:33
1900
Regor Announces Promising Safety And Single Agent Efficacy Data Evaluating RGT-419B In HR+/HER2- Advanced Breast Cancer Patients Who Have Progressed On CDK4/6 Inhibitors And Endocrine Therapy
* RGT-419B, a next generation CDK4 inhibitor, was safe and well tolerated in a First-in-Human Phase 1A single agent dose escalation study. * Monotherapy clinical efficacy was observed in HR+/HER2- advanced breast cancer (ABC) patients who have progressed on CDK4/6 inhibitors (CDK4/6is) and ...
2023-12-08 07:39
1453
AMAZFIT LAUNCHES NEW SPECIAL EDITIONS OF AMAZFIT BALANCE, AND PARTNERS WITH NON-PROFIT ONE TREE PLANTED TO SUPPORT REFORESTATION PROJECTS IN EUROPE
MILPITAS, Calif., Dec. 7, 2023 /PRNewswire/ -- Amazfit
2023-12-08 00:00
1710
2023 SABCS - TransThera announces an oral presentation of tinengotinib clinical data in breast cancer
NANJING, China, Dec. 7, 2023 /PRNewswire/ -- TransThera Sciences (Nanjing) Inc., a clinical-stage biopharmaceutical company focused on inventing differentiated drugs for global patients, today announced that an oral presentation of tinengotinib clinical data in breast cancer was delivered at 202...
2023-12-07 21:00
1196
CRISPR Continuous to Innovate! Exploring the Future of Cell & Gene Therapy, Industry Leaders Converge at the 2024 GenScript Biotech Global Forum
NANJING, China, Dec. 7, 2023 /PRNewswire/ -- The rapid advancement of technology has propelled the field of life sciences into unprecedented growth, constantly expanding our understanding and imagination. Particularly in the field of cellular gene therapy, a series of recent positive developments...
2023-12-07 19:25
1316
Waterdrop Inc. Announces Third Quarter 2023 Unaudited Financial Results
BEIJING, Dec. 7, 2023 /PRNewswire/ -- Waterdrop Inc. ("Waterdrop", the "Company" or "we") (NYSE: WDH), a leading technology platform dedicated to insurance and healthcare service with a positive social impact, today announced its unaudited financial results for the third quarter ended September 3...
2023-12-07 17:00
3155
The GBA Healthcare Group and CUHK Medical Centre announce strategic cooperation to jointly build The GBA Integrated Value Based Care Partnership Ecosystem
HONG KONG, Dec. 7, 2023 /PRNewswire/ -- Today, CUHK Medical Centre ("CUHKMC") and The GBA Healthcare Group (HK) Limited ("GBAH Group") signed a strategic cooperation agreement, to jointly build The GBA Integrated Value Based Care Partnership Ecosystem. Dr Hong FUNG, Chief Executive Officer of ...
2023-12-07 15:41
2579
Unlocking the Potential of Multi-Omics in Precision Medicine: A Conversation with Kazusa DNA Research Institute
CHIBA, Japan, Dec. 7, 2023 /PRNewswire/ -- The integration of multi-omics approaches offers a comprehensive panorama for advancing our comprehension of biology. It now plays a more important role in understanding the roots of diseases, and in expediting precision medicine and catalyzing advanceme...
2023-12-07 15:37
1569
Herbalife Introduces Array of New Wellness Products Tailored to Needs of Consumers in Asia Pacific
HONG KONG, Dec. 7, 2023 /PRNewswire/ -- Herbalife, a global health and wellness company, today announced that during the year to date it has launched 20 unique products (43 product SKUs) inAsia Pacific markets, including formulations specially tailored to the needs of local consumers. The l...
2023-12-07 15:00
2613
Valtech Provides Biotechnology and Technology Startup Orientated Valuation Support
HONG KONG, Dec. 7, 2023 /PRNewswire/ -- Valtech Valuation has recently concluded valuations for several projects within the biotechnology and medical technology sector, specifically focusing on genetic engineering. We are honored to have been entrusted with providing valuation opinions to the man...
2023-12-07 10:00
1612
Week's Top Stories
Most Reposted
Earth Day 2024: Angel Yeast Continues to Tackle Plastic Pollution Challenges With Bio-based Material Solutions
[Picked up by 290 media titles]
2024-04-22 16:00
Trina Solar and PetroGreen Partner to Accelerate Philippine Solar Adoption with 117MW Supply Agreement
[Picked up by 289 media titles]
2024-04-22 06:00
With unique features, Hainan TV opened "The World's Specialty" pavilion at the Expo!
[Picked up by 287 media titles]
2024-04-18 21:26
China's Yiwu Establishes Welcoming Committee to Attract International Buyers
[Picked up by 286 media titles]
2024-04-19 13:25
Animated Life in Yunnan
[Picked up by 281 media titles]
2024-04-18 14:00
Most Read
Combining Sustainability and Cybersecurity: Century Iron & Steel and Century Wind Power Both Receive ISO 27001 Information Security Certification
2024-04-19 18:03
7548
Animated Life in Yunnan
2024-04-18 14:00
7418
With unique features, Hainan TV opened "The World's Specialty" pavilion at the Expo!
2024-04-18 21:26
7211
China's Yiwu Establishes Welcoming Committee to Attract International Buyers
2024-04-19 13:25
5526
IQAX eBL Wins Prestigious APTFF Trade Facilitation Innovation Award 2024
2024-04-18 10:36
3715